 |
|
• |
AusBiotech is pleased to present its submission to the
Productivity Commission’s (PC) study into Science
and Innovation. Our submission affirms the valuable
contribution and impact of the Australian biotechnology
sector, and makes recommendations to help maximise the
opportunities for national benefit.
Click here to view submission
|
|
• |
Melbourne Business School (MBS) Internship Program
MBS recently launched its MBS Internship Program. Unlike
other Australian business schools, MBS has an intake of
full-time MBA students in September as well as January.
As a result of this additional intake, MBS has students
available for internships for up to 12 weeks over May,
June and July; this is in addition to December and
January, when other schools have interns available.
For more information please contact: Michael Toohey,
Director, Careers Services, MBS,
Michael Toohey
Phone: 03 9349 8239
|
|
• |
The Legislation Review of Australia's Prohibition of
Cloning Act 2002 and Research Involving Human Embryos
Act 2002
For more information please visit click
here
|
|
• |
Code of Best Practice for Reporting by Life Sciences
Companies
This code has been jointly developed by ASX and
AusBiotech taking into account international best
practice. Following the release of the Code, a research
project was set up to measure its effectiveness. Part of
this project, which is being done with Professor Michael
Vitale of the Melbourne Business School, is a brief
survey on investor views of the biotechnology industry.
We would appreciate five minutes of your time to
complete the survey by clicking
here |
|
|
AusBiotech is the industry body representing the Australian
biotechnology sector.
With nearly 2400 Members, AusBiotech represents a broad
range of
traditional and entrepreneurial biosciences in human
and animal
health, agriculture and food, diagnostics, medical
and
veterinary devices, informatics, genomics, proteomics,
manufacturing and environmental technologies.
 |
|
